BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37809067)

  • 41. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.
    Fahey JL; Taylor JM; Manna B; Nishanian P; Aziz N; Giorgi JV; Detels R
    AIDS; 1998 Sep; 12(13):1581-90. PubMed ID: 9764776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
    Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
    Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis.
    Yin L; Wang Y
    Cancer Immunol Immunother; 2023 Mar; 72(3):743-758. PubMed ID: 36319716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma.
    Hollander P; Ginman B; Molin D; Enblad G; Amini RM; Glimelius I
    Immunobiology; 2020 Jan; 225(1):151872. PubMed ID: 31787352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma.
    Yan S; Shang Q; Fan Z; Yang Y; Liu Y; Gao H; Chen K; Liang F; Li X; Zhang Q; Yan H
    J Immunol Res; 2022; 2022():5633096. PubMed ID: 36213322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-L1-Expressing Extracellular Vesicles for the Treatment of Pneumonia.
    Wu Y; Wang H; Song A; Wang X; Ma Q; Yao C; Xu J; Dai H; Wang C; Lu T; Xu F
    ACS Biomater Sci Eng; 2023 Nov; 9(11):6464-6471. PubMed ID: 37844209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome.
    Gail MH; Pluda JM; Rabkin CS; Biggar RJ; Goedert JJ; Horm JW; Sondik EJ; Yarchoan R; Broder S
    J Natl Cancer Inst; 1991 May; 83(10):695-701. PubMed ID: 2023270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
    Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
    Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
    Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
    Diamond C; Taylor TH; Im T; Anton-Culver H
    Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular vesicle-mediated immunoregulation in cancer.
    Yamamoto T; Yamamoto Y; Ochiya T
    Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and survival of patients with non-Hodgkin's lymphoma with and without acquired immunodeficiency syndrome.
    Diamond C; Taylor TH; Anton-Culver H
    Hematol Oncol; 2002 Dec; 20(4):177-87. PubMed ID: 12469327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model.
    Kakizaki M; Yamamoto Y; Otsuka M; Kitamura K; Ito M; Kawai HD; Muramatsu M; Kagawa T; Kotani A
    J Biol Chem; 2020 Aug; 295(35):12449-12460. PubMed ID: 32651230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group.
    Biggar RJ; Frisch M; Goedert JJ
    JAMA; 2000 Jul; 284(2):205-9. PubMed ID: 10889594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
    Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
    Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
    de Miguel-Perez D; Russo A; Arrieta O; Ak M; Barron F; Gunasekaran M; Mamindla P; Lara-Mejia L; Peterson CB; Er ME; Peddagangireddy V; Buemi F; Cooper B; Manca P; Lapidus RG; Hsia RC; Cardona AF; Naing A; Kaushal S; Hirsch FR; Mack PC; Serrano MJ; Adamo V; Colen RR; Rolfo C
    J Exp Clin Cancer Res; 2022 Jun; 41(1):186. PubMed ID: 35650597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3.
    Aissani B; Martinez-Maza O; Kaslow RA; Wiener HW; Bream JH; Stosor V; Martinson JJ; Jacobson LP; Shrestha S
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):266-273. PubMed ID: 31026237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group.
    Ragni MV; Belle SH; Jaffe R; Locker J; Duerstein SL; Bass DC; Addiego JE; Aledort LM; Barron LE; Brettler DB; Buchanan GR; Gill JC; Ewenstein BM; Green D; Hilgartner MW; Hoots WK; Kisker CT; Lovrien EW; Rutherford CJ; Sanders NL; Smith KJ; Stabler SP; Swindells S; White GC; Kingsley LA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):78-86. PubMed ID: 8797689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.